Made Scientific and Streamline Bio Launch Exclusive Early Adopter Program to Advance AI-Driven Cell Therapy Manufacturing
The partnership integrates Streamline Bio’s autonomous robotics platform into a GMP-ready environment to accelerate scalable, automated CAR-T and cell therapy production.